The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study of Belzutifan (MK-6482) as Monotherapy and in Combination With Lenvatinib (E7080/MK-7902) With or Without Pembrolizumab (MK-3475) in China Participants With Advanced Renal Cell Carcinoma (MK-6482-010)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT
- Status
- RECRUITING
- Phase
- NA
Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)
- Status
- COMPLETED
- Phase
- N/A
Yorkshire Kidney Screening Trial
- Status
- UNKNOWN
- Phase
- NA
Pembrolizumab and Axitinib as Neoadjuvant Therapy for Locally Advanced Non-metastatic Clear Cell Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
- Status
- COMPLETED
- Phase
- N/A
A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
LPN in Patients With High-complex Renal Tumors
- Status
- COMPLETED
- Phase
- N/A
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
REduced Frequency ImmuNE Checkpoint Inhibition in Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
- Status
- RECRUITING
- Phase
- N/A